RJA
NEO icon

Raymond James & Associates’s NeoGenomics NEO Stock Holding History

Raymond James & Associates’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$258K Buy
+17,520
New +$274K ﹤0.01% 3487
2023
Q3 		– Sell
-11,189
Closed -$180K – 3889
2023
Q2 		$180K Buy
+11,189
New +$184K ﹤0.01% 3506
2022
Q4 		– Sell
-19,476
Closed -$168K – 4012
2022
Q3 		$168K Sell
19,476
-6,778
-26% -$67.3K ﹤0.01% 3490
2022
Q2 		$214K Sell
26,254
-7,413
-22% -$70.8K ﹤0.01% 3464
2022
Q1 		$409K Sell
33,667
-21,328
-39% -$449K ﹤0.01% 3191
2021
Q4 		$1.88M Buy
54,995
+767
+1% +$30K ﹤0.01% 2222
2021
Q3 		$2.62M Sell
54,228
-17,100
-24% -$792K ﹤0.01% 1908
2021
Q2 		$3.22M Buy
71,328
+17,621
+33% +$781K ﹤0.01% 1786
2021
Q1 		$2.59M Sell
53,707
-13,592
-20% -$708K ﹤0.01% 1843
2020
Q4 		$3.62M Buy
67,299
+1,363
+2% +$61.6K ﹤0.01% 1519
2020
Q3 		$2.43M Sell
65,936
-2,437
-4% -$90.6K ﹤0.01% 1629
2020
Q2 		$2.12M Sell
68,373
-28,593
-29% -$792K ﹤0.01% 1703
2020
Q1 		$2.68M Buy
96,966
+6,420
+7% +$192K ﹤0.01% 1410
2019
Q4 		$2.65M Buy
90,546
+22,493
+33% +$536K ﹤0.01% 1653
2019
Q3 		$1.3M Buy
68,053
+21,337
+46% +$500K ﹤0.01% 2029
2019
Q2 		$1.02M Buy
46,716
+4,144
+10% +$90.9K ﹤0.01% 2201
2019
Q1 		$871K Buy
42,572
+1,716
+4% +$29.8K ﹤0.01% 2288
2018
Q4 		$515K Buy
+40,856
New +$609K ﹤0.01% 2533
2017
Q4 		– Sell
-10,485
Closed -$117K – 3494
2017
Q3 		$117K Buy
+10,485
New +$102K ﹤0.01% 3162

Other funds holding NEO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Raymond James & Associates's NEO Position: Q3 2024 in Review

Raymond James & Associates opened a new position in NeoGenomics (NEO) in Q3 2024: 17,520 shares worth $258K. The stake represents ﹤0.01% of the portfolio and ranks #3487 among its holdings. This is a return to the name: Raymond James & Associates previously reported a position in NEO as recently as Q2 2023.

Raymond James & Associates first reported a position in NEO in Q3 2017 and has held it in 19 quarters since. The position peaked at $3.62M in Q4 2020. 270 funds tracked by Wall St. Rank hold NEO as of Q3 2024.

  • Raymond James & Associates held 17,520 shares of NeoGenomics worth $258K as of Q3 2024.
  • NeoGenomics was a new Raymond James & Associates position in Q3 2024.
  • NeoGenomics made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #3487 holding.
  • Raymond James & Associates first reported a position in NeoGenomics in Q3 2017 and has held it in 19 quarters since.
  • Raymond James & Associates's NeoGenomics position peaked at $3.62M in Q4 2020.
  • 270 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.